Pharmacies and healthcare providers may still dispense unexpired Paxlovid doses, labeled with emergency use authorization, through this date. After March 8, all doses must be returned to Pfizer or disposed of properly, the FDA said in a Jan. 29 notice.
The revision comes about eight months after the FDA approved Pfizer’s new drug application for Paxlovid to treat COVID-19 in adults at high -risk of severe complications, including hospitalization or death.
The agency will continue emergency use authorization for Paxlovid in high-risk pediatric patients ages 12 and up.
Learn more here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.